Serial Number | 85583345 |
Word Mark | MOLECULARHEALTH |
Filing Date | Thursday, March 29, 2012 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, November 19, 2021 |
Registration Number | 4710227 |
Registration Date | Tuesday, March 31, 2015 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, July 1, 2014 |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Disclaimer with Predetermined Text | "MOLECULAR HEALTH" |
Description of Mark | The mark consists of circle within a circle and an arrow within the inner circle and the word "MOLECULARHEALTH" to the right of the image. |
Goods and Services | Data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer |
Goods and Services | Data collection for medical and scientific research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for medical and scientific research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others |
Goods and Services | Providing an online database featuring medical, pharmaceutical and genomic information for medical diagnostic or treatment purposes; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; medical consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others |
Pseudo Mark | MOLECULAR HEALTH |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, November 19, 2021 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, November 19, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, November 19, 2021 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Molecular Health GMBH |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Heidelberg 69115 DD |
Party Name | Molecular Health GMBH |
Party Type | 21 - New Owner After Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | Heidelberg 69115 DD |
Party Name | Molecular Health AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | 4010 Basel CH |
Party Name | Molecular Health AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | 4010 Basel CH |
Event Date | Event Description |
Friday, November 19, 2021 | CANCELLED SEC. 8 (6-YR) |
Tuesday, March 31, 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Tuesday, March 31, 2015 | REGISTERED-PRINCIPAL REGISTER |
Thursday, February 26, 2015 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
Thursday, February 26, 2015 | NOTICE OF ALLOWANCE CANCELLED |
Tuesday, February 24, 2015 | TEAS DELETE 1(B) BASIS RECEIVED |
Thursday, August 28, 2014 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, August 26, 2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Wednesday, August 20, 2014 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Wednesday, July 2, 2014 | NOTICE OF PUBLICATION |
Tuesday, July 1, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 1, 2014 | PUBLISHED FOR OPPOSITION |
Wednesday, June 11, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, May 23, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Thursday, May 22, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, May 15, 2014 | EXAMINER'S AMENDMENT ENTERED |
Thursday, May 15, 2014 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, May 15, 2014 | EXAMINERS AMENDMENT E-MAILED |
Thursday, May 15, 2014 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, April 24, 2014 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
Thursday, April 24, 2014 | PRIORITY ACTION E-MAILED |
Thursday, April 24, 2014 | PRIORITY ACTION WRITTEN |
Thursday, March 20, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, March 20, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, March 14, 2014 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Wednesday, September 25, 2013 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Wednesday, September 25, 2013 | INQUIRY TO SUSPENSION E-MAILED |
Wednesday, September 25, 2013 | SUSPENSION INQUIRY WRITTEN |
Thursday, September 19, 2013 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
Thursday, March 14, 2013 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, March 14, 2013 | LETTER OF SUSPENSION E-MAILED |
Thursday, March 14, 2013 | SUSPENSION LETTER WRITTEN |
Thursday, March 7, 2013 | EXAMINER'S AMENDMENT ENTERED |
Thursday, March 7, 2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, March 7, 2013 | EXAMINERS AMENDMENT E-MAILED |
Thursday, March 7, 2013 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, January 31, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, January 31, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, January 24, 2013 | ASSIGNED TO LIE |
Tuesday, January 22, 2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, January 22, 2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Sunday, July 22, 2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Sunday, July 22, 2012 | NON-FINAL ACTION E-MAILED |
Sunday, July 22, 2012 | NON-FINAL ACTION WRITTEN |
Tuesday, July 10, 2012 | ASSIGNED TO EXAMINER |
Thursday, April 5, 2012 | NOTICE OF DESIGN SEARCH CODE MAILED |
Wednesday, April 4, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Monday, April 2, 2012 | NEW APPLICATION ENTERED IN TRAM |